TrialPloS one2019

Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

Paola Anna Jablonska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.